Showing 8 of 8 recruiting trials for “Hodgkin lymphoma”
RecruitingNCT07356882 ↗
European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma
👨⚕️ Mathieu SIMONIN, MD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Nov 2025View details ↗
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma
👨⚕️ Andreas Engert, Prof., 1st Department of Medicine, Cologne Universit Hospital📍 1 site📅 Started Mar 2024View details ↗
A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma
RecruitingNCT06822855 ↗
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
👨⚕️ Luminari Stefano, MD, Azienda USL - IRCCS di Reggio Emilia📍 12 sites📅 Started Jun 2022View details ↗
Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin
RecruitingNCT01790152 ↗
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →